Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Expression of soluble Fas and soluble FasL in human nucleus pulposus cells.

Sun Z, Wan ZY, Liu ZH, Guo YS, Yin JB, Duan CG, Gao Y, Li T, Wang HQ, Luo ZJ.

Int J Clin Exp Pathol. 2013 Jul 15;6(8):1567-73. Print 2013.

2.

FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells.

Sun Z, Wan ZY, Guo YS, Wang HQ, Luo ZJ.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2376-85. eCollection 2013.

3.

FasL expression on human nucleus pulposus cells contributes to the immune privilege of intervertebral disc by interacting with immunocytes.

Liu ZH, Sun Z, Wang HQ, Ge J, Jiang TS, Chen YF, Ma Y, Wang C, Hu S, Samartzis D, Luo ZJ.

Int J Med Sci. 2013 Jun 21;10(8):1053-60. doi: 10.7150/ijms.6223. Print 2013.

4.

[Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].

Jun EJ, Han JY, Sun HS.

Korean J Hepatol. 2006 Dec;12(4):507-14. Korean.

5.

The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.

Erdoğan B, Uzaslan E, Budak F, Karadağ M, Ediger D, Oral B, Göral G, Ege E, Gözü O.

Tuberk Toraks. 2005;53(2):127-31.

PMID:
16100648
6.

Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes.

Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA.

Arthritis Res Ther. 2010;12(1):R22. doi: 10.1186/ar2929. Epub 2010 Feb 11.

7.

Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration.

Erwin WM, Islam D, Inman RD, Fehlings MG, Tsui FW.

Arthritis Res Ther. 2011;13(6):R215. doi: 10.1186/ar3548. Epub 2011 Dec 29.

8.

Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.

Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.

J Lab Clin Med. 2000 Oct;136(4):320-7.

PMID:
11039853
9.
10.

The cytokine and chemokine expression profile of nucleus pulposus cells: implications for degeneration and regeneration of the intervertebral disc.

Phillips KL, Chiverton N, Michael AL, Cole AA, Breakwell LM, Haddock G, Bunning RA, Cross AK, Le Maitre CL.

Arthritis Res Ther. 2013;15(6):R213.

11.

[Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis].

Yuan BJ, Liu ZZ, Ding XR, Zou JM.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2006 Feb;24(2):96-8. Chinese.

PMID:
16600114
12.

Significance of Fas and Fas ligand in tuberculous lymphadenitis.

Mustafa T, Mogga SJ, Mfinanga SG, Mørkve O, Sviland L.

Immunology. 2005 Feb;114(2):255-62.

13.

Expression of FasL and Fas protein and their soluble form in patients with hypersensitivity pneumonitis.

Kuwano K, Hagimoto N, Kawasaki M, Nakamura N, Shirakawa K, Maeyama T, Hara N.

Int Arch Allergy Immunol. 2000 Jul;122(3):209-15.

PMID:
10899765
14.

Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration.

Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK, Le Maitre CL.

Arthritis Res Ther. 2014 Aug 20;16(5):416. doi: 10.1186/s13075-014-0416-1.

15.

Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis.

Sugita S, Taguchi C, Takase H, Sagawa K, Sueda J, Fukushi K, Hikita N, Watanabe T, Itoh K, Mochizuki M.

Br J Ophthalmol. 2000 Oct;84(10):1130-4.

16.

Identification of cell surface-specific markers to target human nucleus pulposus cells: expression of carbonic anhydrase XII varies with age and degeneration.

Power KA, Grad S, Rutges JP, Creemers LB, van Rijen MH, O'Gaora P, Wall JG, Alini M, Pandit A, Gallagher WM.

Arthritis Rheum. 2011 Dec;63(12):3876-86. doi: 10.1002/art.30607.

17.

Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1.

Sakamoto N, Mukae H, Fujii T, Kakugawa T, Kaida H, Kadota J, Kohno S.

Respir Med. 2004 Mar;98(3):213-9.

PMID:
15002756
18.

Low soluble Fas (sFas) and sFas ligand (sFasL) content in breast milk after preterm as opposed to term delivery.

Jochum F, Loui A, Weber A, Felderhoff-Mueser U, Bührer C, Dudenhausen JW, Obladen M.

Acta Paediatr. 2005 Feb;94(2):143-6.

PMID:
15981745
19.

Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.

Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.

Int Immunol. 2009 Mar;21(3):237-43. doi: 10.1093/intimm/dxn142. Epub 2009 Jan 30.

20.

Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc.

Tolofari SK, Richardson SM, Freemont AJ, Hoyland JA.

Arthritis Res Ther. 2010;12(1):R1. doi: 10.1186/ar2898. Epub 2010 Jan 5.

Items per page

Supplemental Content

Write to the Help Desk